Contract Development Manufacturing Organizations Market Report 2026
Global Outlook – By Service (CMO, CRO), By Product (Small Molecules, Biologics), By End User (Big Pharma, Small and Mid-size Pharma, Generic Pharmaceutical Companies, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Contract Development Manufacturing Organizations Market Overview
• Contract Development Manufacturing Organizations market size has reached to $274.79 billion in 2025 • Expected to grow to $503.82 billion in 2030 at a compound annual growth rate (CAGR) of 12.9% • Growth Driver: Driving Forces Of Growth In The Contract Development Manufacturing Organizations Market • Market Trend: Increasing Focus On Innovative Developments To Provide Reliable Services To Their Customers • North America was the largest region in 2025.What Is Covered Under Contract Development Manufacturing Organizations Market?
Contract development manufacturing organizations refer to businesses that work on a contract basis with the pharmaceutical sector to provide medication development and manufacturing services. These businesses enable the pharmaceutical industry to outsource some of its operations, freeing up crucial time to concentrate on medication development and marketing. The contract development manufacturing organizations are segmented by service into CMO, CRO, by product into small molecules, biologics and by end user into big pharma, small and mid-size pharma, generic pharmaceutical companies, and other end users.
What Is The Contract Development Manufacturing Organizations Market Size and Share 2026?
The contract development manufacturing organizations market size has grown rapidly in recent years. It will grow from $274.79 billion in 2025 to $309.9 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to cost optimization through outsourcing, rising r&d expenditure in pharmaceuticals, growing generic drug production, increasing regulatory complexity, limited in-house manufacturing capacity.What Is The Contract Development Manufacturing Organizations Market Growth Forecast?
The contract development manufacturing organizations market size is expected to see rapid growth in the next few years. It will grow to $503.82 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to growth of biologics and advanced therapies, increasing demand for flexible manufacturing capacity, expansion of small and mid-size pharma companies, rising clinical trial activity, global pharmaceutical pipeline growth. Major trends in the forecast period include increased outsourcing of drug development and manufacturing, growing demand for integrated cdmo services, expansion of biologics and biosimilars manufacturing, rising focus on regulatory compliance and quality assurance, capacity expansion in emerging pharmaceutical markets.
Global Contract Development Manufacturing Organizations Market Segmentation
1) By Service: CMO, CRO 2) By Product: Small Molecules, Biologics 3) By End User: Big Pharma, Small and Mid-size Pharma, Generic Pharmaceutical Companies, Other End Users Subsegments: 1) By CMO (Contract Manufacturing Organization): API (Active Pharmaceutical Ingredient) Manufacturing, Formulation Development, Finished Product Manufacturing, Packaging Services 2) By CRO (Contract Research Organization): Preclinical Research Services, Clinical Trial Management, Data Management And Biostatistics, Regulatory Affairs ConsultingWhat Is The Driver Of The Contract Development Manufacturing Organizations Market?
The growing demand for pharmaceutical products due to the increase in chronic diseases and the geriatric population contributed to the growth of the contract development manufacturing organizations market. Rising chronic diseases and geriatric population has enabled pharmaceutical companies to manufacture biologics and biosimilar quickly, and most pharmaceutical firms have contracted contract production and manufacturing organizations operating on a contractual basis to handle and coordinate the company's tasks, operations and tests. For instance, in November 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based, trade association, the total pharmaceutical production in Europe accounted for €390,000 million ($422,803 million) in 2023, up from €363,300 million ($393,857 million) in 2022. Therefore, the growing demand for pharmaceutical products is driving the growth of the contract development manufacturing organizations industry.Key Players In The Global Contract Development Manufacturing Organizations Market
Major companies operating in the contract development manufacturing organizations market are Recipharm AB, AbbVie Contract Manufacturing LLC, Almac Group Limited, Baxter BioPharma Solutions LLC, Boehringer Ingelheim International GmbH, Catalent Pharma Solutions Inc., CMIC Holdings Co. Ltd., Covance Inc., Evotec SE, Famar Health Care Services Madrid SA, Jubilant Life Sciences Limited, Lonza Group Ltd., Patheon UK Limited, Pfizer CentreOne, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, Advanced BioScience Laboratories Inc., Adare Pharmaceuticals Inc., Aenova Holding GmbH, Ajinomoto Bio-Pharma Services, Albany Molecular Research Inc., Cambrex Corporation, CordenPharma International GmbH, EirGen Pharma Limited, Grand River Aseptic Manufacturing, Hovione LLC, Metrics Contract Services, NextPharma Technologies Holding Limited, Nitto Avecia Pharma Services Inc., Piramal Pharma Solutions Inc., Siegfried Holding AG, Therapure Biopharma Inc., Velesco Pharmaceutical Services, WuXi PharmaTech (Cayman) Inc.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Contract Development Manufacturing Organizations Market Trends and Insights
Major companies operating in the contract development and manufacturing organizations market are focusing on innovative developments such as Lifera to drive revenues in their market. Lifera, a commercial-scale contract development and manufacturing organization (CDMO). For instance, in June 2023, Public Investment Fund (PIF), Saudi Arabia’s global investment organization launched Lifera. The production of vital biopharmaceutical goods, such as insulin, vaccinations, monoclonal antibodies, plasma treatments, cell and gene therapies, and cutting-edge small chemicals, will be Lifera's primary focus. To increase local capacity and support domestic manufacturing in this industry, the corporation will also form alliances with top domestic and foreign businesses and draw in specific investments. Driving formulation development, medication development, and manufacturing are some of Lifera's objectives.What Are Latest Mergers And Acquisitions In The Contract Development Manufacturing Organizations Market?
In December 2023, Ajinomoto Co., Inc., a Japan-based provider of biopharma services, amino acid–based technologies, and contract development and manufacturing solutions, acquired Forge Biologics for $620 million. With this acquisition, Ajinomoto aims to expand its capabilities in viral vector and plasmid gene therapy manufacturing to strengthen its global contract development and manufacturing service offerings. Forge Biologics is a US-based provider of adeno-associated virus and plasmid DNA manufacturing, process development, and end-to-end gene therapy CDMO services.
Regional Insights
North America was the largest region in contract development manufacturing organizations market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Contract Development Manufacturing Organizations Market?
The contract development manufacturing organizations market includes revenues earned by entities by formulation, analytical services, blending, coating, and converting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Contract Development Manufacturing Organizations Market Report 2026?
The contract development manufacturing organizations market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the contract development manufacturing organizations industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Contract Development Manufacturing Organizations Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $309.9 billion |
| Revenue Forecast In 2030 | $503.82 billion |
| Growth Rate | CAGR of 12.8% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Service, Product, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Recipharm AB, AbbVie Contract Manufacturing LLC, Almac Group Limited, Baxter BioPharma Solutions LLC, Boehringer Ingelheim International GmbH, Catalent Pharma Solutions Inc., CMIC Holdings Co. Ltd., Covance Inc., Evotec SE, Famar Health Care Services Madrid SA, Jubilant Life Sciences Limited, Lonza Group Ltd., Patheon UK Limited, Pfizer CentreOne, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, Advanced BioScience Laboratories Inc., Adare Pharmaceuticals Inc., Aenova Holding GmbH, Ajinomoto Bio-Pharma Services, Albany Molecular Research Inc., Cambrex Corporation, CordenPharma International GmbH, EirGen Pharma Limited, Grand River Aseptic Manufacturing, Hovione LLC, Metrics Contract Services, NextPharma Technologies Holding Limited, Nitto Avecia Pharma Services Inc., Piramal Pharma Solutions Inc., Siegfried Holding AG, Therapure Biopharma Inc., Velesco Pharmaceutical Services, WuXi PharmaTech (Cayman) Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |